Adarsh Plant Protect closes trading window from Oct 1 for Q2FY27 results
- Trading window closes from October 1, 2026
- Restriction applies to promoters, directors, and insiders
- Window reopens 48 hours after Q2FY27 results declaration

*this image is generated using AI for illustrative purposes only.
Adarsh Plant Protect Limited will close its trading window for dealing in securities starting October 1, 2026. This restriction precedes the announcement of un-audited financial results for the quarter and half-year ended September 30, 2026.
The company informed BSE Limited that the closure complies with SEBI (Prohibition of Insider Trading) Regulations, 2015, and relevant circulars regarding trading restriction periods. The window remains closed for all designated persons, including promoters, directors, key managerial personnel, designated employees, insiders, and their immediate relatives.
Compliance and Timeline Details
The trading restriction is effective from the start date until 48 hours after the declaration of the Q2FY27 and H1FY27 financial results. This measure ensures adherence to regulatory standards preventing insider trading during sensitive periods preceding earnings disclosures.
| Parameter | Detail |
|---|---|
| Company | Adarsh Plant Protect Limited |
| Trading Window Closure Start | October 1, 2026 |
| Reporting Period | Quarter and half-year ended September 30, 2026 |
| Regulatory Basis | SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| Restriction Duration | Until 48 hours post-results declaration |
The intimation was submitted by Dhwani Shah, Company Secretary and Compliance Officer, to the Corporate Relationship Department of BSE Limited on September 24, 2026.
Historical Stock Returns for Adarsh Plant Protect
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.71% | -5.17% | -6.70% | -14.29% | -1.96% | +275.00% |
How might the upcoming Q2FY27 financial results influence Adarsh Plant Protect's stock volatility once the trading window reopens?
Are there any pending institutional investor positions or recent block deals that could be impacted by the insider trading restrictions?
What are the current analyst consensus estimates for revenue and EBITDA margins for the quarter ending September 30, 2026?

































